Prognostic model for survival of local recurrent nasopharyngeal carcinoma with intensity-modulated radiotherapy
- PMID: 24335924
- PMCID: PMC3899759
- DOI: 10.1038/bjc.2013.715
Prognostic model for survival of local recurrent nasopharyngeal carcinoma with intensity-modulated radiotherapy
Abstract
Background: Intensity-modulated radiotherapy (IMRT) is the main salvage treatment for advanced locally recurrent nasopharyngeal carcinoma (NPC); however, survival outcomes vary. We aimed to construct a prognostic-score model to identify patients who could benefit from salvage IMRT.
Methods: This retrospective study involved 251 patients with locally recurrent NPC. The following parameters were analysed following IMRT: patient performance status, age, gender, late complications, T-stage of recurrence, synchronous nodal recurrence, primary gross tumour volume (GTV-nx), disease-free interval, re-irradiation dose and chemotherapy. The model was based on the hazard ratio coefficients of six significantly negative prognostic factors for survival.
Results: Significantly negative prognostic factors included Karnofsky Performance Status ≤70, age >50 years, late complications, recurrent T(3-4) stage, synchronous nodal recurrence and GTV-nx >30 cm(3). Three subgroups were defined according to model scores: low risk (0-4), intermediate risk (5-8) and high risk (9-15). The 5-year overall survival rates were 64.3%, 32.2% and 7.7%, respectively. The main cause of death was radiation-induced complications.
Conclusion: The prognostic-score model demonstrated that re-irradiation with IMRT is suitable for low-risk and intermediate-risk patients but may be unsuitable for high-risk patients. Further research into the protection of critical adjacent organs to reduce late complications in these patients is warranted.
Figures




References
-
- Al-Sarraf M, LeBlanc M, Giri PG, Fu KK, Cooper J, Vuong T, Forastiere AA, Adams G, Sakr WA, Schuller DE, Ensley JF. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099. J Clin Oncol. 1998;16:1310–1317. - PubMed
-
- Chow E, Payne D, O'Sullivan B, Pintilie M, Liu FF, Waldron J, Warde P, Cummings B. Radiotherapy alone in patients with advanced nasopharyngeal cancer: comparison with an intergroup study Is combined modality treatment really necessary. Radiother Oncol. 2002;63:269–274. - PubMed
-
- Chua DT, Sham JS, Hung KN, Leung LH, Au GK. Predictive factors of tumor control and survival after radiosurgery for local failures of nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2006;66:1415–1421. - PubMed
-
- Chua DT, Sham JS, Leung LH, Au GK. Re-irradiation of nasopharyngeal carcinoma with intensity-modulated radiotherapy. Radiother Oncol. 2005;77:290–294. - PubMed
-
- Corry J, Fisher R, Rischin D, Peters LJ. Relapse patterns in WHO 2/3 nasopharyngeal cancer: is there a difference between ethnic Asian vs non-Asian patients. Int J Radiat Oncol Biol Phys. 2006;64:63–71. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources